Ceragon Networks Ltd.
CRNT
$2.74
$0.0250.92%
Weiss Ratings | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D+ | |||
Rating Factors | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Weak | |||
Solvency Index | Good | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.17 | |||
Price History | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -7.22% | |||
30-Day Total Return | -9.70% | |||
60-Day Total Return | 6.72% | |||
90-Day Total Return | 44.39% | |||
Year to Date Total Return | 27.96% | |||
1-Year Total Return | 49.17% | |||
2-Year Total Return | 41.36% | |||
3-Year Total Return | -23.08% | |||
5-Year Total Return | -35.41% | |||
52-Week High % Change | -18.34% | |||
52-Week Low % Change | 76.92% | |||
Price | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $3.38 | |||
52-Week Low Price | $1.56 | |||
52-Week Low Price (Date) | Oct 23, 2023 | |||
52-Week High Price (Date) | Mar 25, 2024 | |||
Valuation | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 233.80M | |||
Enterprise Value | 255.77M | |||
Price/Earnings (TTM) | 568.75 | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | -102.02% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.32 | |||
Price/Book (Q) | 1.74 | |||
Enterprise Value/Revenue (TTM) | 1.46 | |||
Price | $2.70 | |||
Enterprise Value/EBITDA (TTM) | 15.72 | |||
Enterprise Value/EBIT | 22.69 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 85.05M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 3 543 1000 | |||
Address | -- | |||
Website | www.ceragon.com | |||
Country | Israel | |||
Year Founded | 1996 | |||
Profitability | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $2.08 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | 19.63% | |||
Earnings Growth (Q YOY) | 91.99% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 88.82% | |||
Balance Sheet | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 28.24M | |||
Cash Per Share (Q) | $0.33 | |||
Total Current Assets (Q) | 217.94M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 134.02M | |||
Current Ratio (Q) | 1.639 | |||
Book Value Per Share (Q) | $1.57 | |||
Total Assets (Q) | 298.53M | |||
Total Current Liabilities (Q) | 132.95M | |||
Total Debt (Q) | 50.21M | |||
Total Liabilities (Q) | 164.51M | |||
Total Common Equity (Q) | 134.02M | |||
Cash Flow | CRNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||